The first paper was a collaboration with the Moores Cancer Center and several biotechnology companies, describing the state of the art in cancer immunotherapy, and proposing future directions.
The second paper discussed the possibility of stimulating regeneration of injured lung stem cells using specific types of laser and
light based interventions, this was a collaboration between the University of Utah and the University of California, San Diego.
The third paper, a collaboration between a nutraceutical company and Indiana University, demonstrated the beneficial effects of a nutritional supplement on circulating stem cells in healthy volunteers.
The fourth publication was the first successful use of two different types of stem cells in a patient with heart failure, which resulted in a profound improvement.
The fifth publication is a report of 114 patients that were treated with umbilical cord blood stem cells and demonstrated safety and signals of efficacy in collaboration with a Chinese Biotech company.
The sixth publication was
successful treatment of a spinal cord injury patient with stem cells.
The seventh publication was the basis for an investigational new drug (IND) application to the FDA, describing
use of fat stem cells to treat aplastic anemia.
Paid for by Famela Ramos for Congress